| |
|
|
|
Oxford Global, London, UK
21 - 22 March 2022
https://www.oxfordglobal.co.uk/biologics-series/agenda/download-agenda/
|
|
|
|
|
|
|
|
Organized by:
|
|
OxfordGlobal |
|
|
Invited Speakers:
|
|
PETER SLAVNY Chief Technology Officer, Iontas MAHENDRA DEONARAIAN Chief Executive & Science Officer, Antikor Biopharma AG (Joining Online) JOEL RICHARD Chief Development Officer, MedinCell STEVE HOOD Senior Scientific Director, Imaging Expertise Networks, GlaxoSmithKline ERNST WEBER Head of Molecular Design & Engineering, Bayer AG TANJA GAISSMAIER Scientist, Potency Skill Center, Boehringer Ingelheim SERGIO MALLART Principal Scientist, Sanofi DAVID HUMPHREYS Senior Director, New Modalities & Therapeutics, UCB Pharma NEIL BIRKETT Associate Director, CMC Process Development, Crescendo Biologics Ltd (Joining Online) WU SU Director of Medicinal Chemistry, Team Leader in New Modalities Medicinal Chemistry, AstraZeneca MICHAEL KELLER Senior Principal Scientist, Roche DENICE CHAN Senior Scientist, Cancer Research UK - AstraZeneca Antibody Alliance Laboratory STEVE GRANT Manager, Biopharm Molecular Discovery, GlaxoSmithKline DILYANA DIMOVA Data Scientist, Sanofi KATRIN REICHEL Senior Data Scientist, Sanofi-Aventis Deutschland GmbH FRANCOIS BERTELLI Head of Platform Development, Avvinity SEBASTIEN VIOLINI Scientist, Technical Research & Development, Roche Pharmaceuticals PAUL DALBY Professor, University College London DAN BACH KRISTENSEN Principal Scientist, Symphogen A/S (Joining Online) MOHAMED ELSAYED Senior Research Fellow, Biotechnology Discovery Research, Eli Lilly & Company SILVIA SONZINI Associate Principal Scientist, AstraZeneca ALESSANDRO SANNINO Senior Expert Science & Technology, Novartis NICOLAS BASSE Head of Immuno-oncology Cluster, Sanofi ANGUS SINCLAIR Senior Vice President, Immunooncology, IGM Biosciences ANNA HINE Professor, Aston University (Joining Online) MANOJ PAL Principal Scientist, Analytical & Formulation Development, Ambrx, inc. (Joining Online) HETAL SARVAIYA Associate Director, DMPK-BA, AbbVie CATHERINE ROWLAND Team Leader, Bicycle Therapeutics CHRIS LEITHEISER Principal Scientist, Bicycle Therapeutics ALEX MACPHERSON Senior Principle Scientist, UCB KATRINA CAMPBELL Professor, Queen’s University Belfast SARAH LOVELOCK UKRI Future Leaders Fellow, University of Manchester MARC VENDRELL Professor and Chemistry Lead of API Synthesis Unit, University of Edinburgh MARTIN EDELMANN Senior Scientist, Roche TOM BROWN Professor of Nucleic Acid Chemistry, University of Oxford ALETHEA TABOR Professor of Organic Chemistry, University College London HARALD KOLMAR Professor, Technical University of Darmstadt CONFIRMED SPEAKERS – DAY ONE CONFIRMED SPEAKERS – DAY TWO CONFIRMED SPEAKERS – DAY TWO ROBIN LÖVING Chief Scientific Officer, Salipro Biotech AB LAURA VON SCHANTZ Vice President, Discovery, Alligator Bioscience AG ALI TAVASSOLI Chief Scientific Officer, Curve Therapeutics, Professor, University of Southampton ILIAS JIMIDAR Associate Director, Analytical Integration, Janssen TREVOR WILKINSON Associate Director, AstraZeneca IMMANUEL LERNER Chief Executive Officer, Pepticom DENIS DRYGIN Chief Scientific Officer, Regulus Therapeutics FRANCIS DUFFIEUX Head of Protein Purification & Microbial Fermentation, Sanofi BARBARA HEBEIS Director, Bioassay, AstraZeneca KRISTIAN STRØMGAARD Chief Executive Officer, Avilex Pharma, Professor, University of Copenhagen MIN FANG Senior Scientist, National Institute for Biological Standards & Control (Joining Online) MARLON HINNER Principal Scientist, Roche Pharmaceuticals DANIEL FLEISCHANDERL Head of Upstream Development, Boehringer Ingelheim DMITRY SAMARSKY Chief Technology Officer, Sirnaomics ANGUS SINCLAIR Senior Vice President, Immunooncology, IGM Biosciences ENKELEJDA MIHO Professor, FHNW University of Applied Sciences and Arts Northwestern Switzerland PETER MOLLOY Director of Proteins Science Research, Immunocore STEFAN ZIELONKA Associate Director; Protein Engineering & Antibody Technologies, Merck KGaA SUZANNE BAL Scientist, Merus (Joining Online) YI YANG Lead Scientist, Ferring Pharmaceuticals IJEOMA FLORENCE UCHEGBU Professor of Pharmaceutical Nanoscience, University College London NICHOLAS MITCHELL Assistant Professor & Group Leader, University of Nottingham NAGY HABIB Founder, Head of R&D, MiNA Therapeutics (Joining Online) GENE LIAU Chief Scientific Officer, Stoke Therapeutics MARTIN AKERMAN Chief Technology Officer & Co-Founder, Envisagenics COLETTE JOHNSTON Vice President, Discovery, Crescendo Biologics Ltd NARESH BADGUJAR Associate Principle Scientist, AstraZeneca SAM HEYWOOD Director, UCB (Joining Online) TOMAS LEEK Director, AstraZeneca (Joining Online) AMY DOTY Associate Principal Scientist, MSD STEFFEN GOLETZ Professor, Technical University of Denmark CONFIRMED SPEAKERS – DAY THREE (DIGITAL ONLY DAY) (Joining Online) JEFFREY LUO Associate Scientific Director, Janssen (Joining Online) ROY BAYNES Senior Vice President and Head Global Clinical Development (Joining Online) NIGEL DAVIES Associate Director, Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca (Joining Online) HELEN PAYNE Senior Scientist, High Throughput Characterisation, GlaxoSmithKline (Joining Online) ALEX JACOBITZ Senior Data Scientist, Amgen (Joining Online) ANDREW ARGO Scientist I, Biogen (Joining Online) FENG YANG Principal Scientist, Genentech
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
https://www.oxfordglobal.co.uk/biologics-series/book-now/
|
|
|
E-mail:
|
|
h.liddiard@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|